MARKET

PCLOF

PCLOF

Pharmacielo
OTCQX

Real-time Quotes | Nasdaq Last Sale

0.384
+0.054
+16.36%
Closed 12:56 06/24 EDT
OPEN
0.320
PREV CLOSE
0.330
HIGH
0.384
LOW
0.320
VOLUME
25.44K
TURNOVER
9.65K
52 WEEK HIGH
1.540
52 WEEK LOW
0.320
MARKET CAP
57.80M
P/E (TTM)
-3.0843
1D
5D
1M
3M
1Y
5Y
PharmaCielo Ships CBD Full Spectrum Oil To A Brazilian Pharmaceutical Company
PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., shipped an initial shipment of a CBD full spectrum ex...
Benzinga · 06/06 14:11
BRIEF-Pharmacielo Announces Shipment Of CBD Full Spectrum Oil To Brazilian Pharmaceutical Customer
reuters.com · 06/06 11:55
PharmaCielo Announces Shipment of CBD Full Spectrum Oil to a Brazilian Pharmaceutical Customer
PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today...
CNW Group · 06/06 11:30
PharmaCielo Q1 Revenue Increases 77.92% YoY, Discusses International Markets
PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) Q1 2022 revenue was CA$1.2 million ($947,000) compared to CA$675,000 in Q1 2021, an increase of 77.92%.
Benzinga · 05/31 13:52
PharmaCielo GAAP EPS of -C$0.02, revenue of C$1.2M
PharmaCielo press release (OTCQX:PCLOF): Q1 GAAP EPS of -C$0.02. Revenue of C$1.2M (+76.5% Y/Y). PharmaCielo had cash equivalents of C$1.4M at March 31, 2022, compared to C$5.3M at December 31,
Seekingalpha · 05/31 09:06
BRIEF-Pharmacielo Announces Financial Results For The First Quarter Ended March 31, 2022
reuters.com · 05/30 12:53
PharmaCielo Announces Financial Results for the First Quarter Ended March 31, 2022
PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced fi...
CNW Group · 05/30 11:55
PharmaCielo Enters Spanish Market With Initial Shipment Of 300Kg Of CBD Full Spectrum Oil To Extractions Solutions
PharmaCielo Ltd.
Benzinga · 05/24 15:06
More
No Data
Learn about the latest financial forecast of PCLOF. Analyze the recent business situations of Pharmacielo through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average PCLOF stock price target is 1.939 with a high estimate of 1.939 and a low estimate of 1.939.
High1.939
Average1.939
Low1.939
Current 0.3840
EPS
Actual
Estimate
-0.03-0.010.010.03
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+2.68%
Pharmaceuticals & Medical Research
+2.48%
Key Executives
President/Chief Executive Officer
Henning Von Koss
Chief Financial Officer
Scott Laitinen
Chief Operating Officer
Andres Botero
Other
David Gordon
Lead Director/Independent Director
Marc Lustig
Independent Director
Douglas Bache
Independent Director
Claudia Jimenez
Independent Director
Matteo Pellegrini
No Data
No Data
About PCLOF
Pharmacielo Ltd, formerly AAJ Capital 1 Corp, is a Canada-based company that is engaged in the alternative medicine sector. The Company produces cannabis oils. It offers medicinal-grade oil extracts and related products, which provide relief and wellness formulas for patients in need, including those requiring higher levels of tetrahydrocannabinol (THC). The Company's wholly-owned subsidiary is PharmaCielo Colombia Holdings SAS based in Colombia. The Company works together with Cooperativa Caucannabis and more than 60 local regional farmer members in Cauca, Colombia to cultivate cannabis for the production of standardized, medicinal-grade oil extracts and related products. Pharmacielo Ltd holds Colombian licenses for cannabis.

Webull offers kinds of Pharmacielo Ltd stock information, including OTCQX:PCLOF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCLOF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PCLOF stock methods without spending real money on the virtual paper trading platform.